Cargando…

Severe Antithrombin Deficiency May be Associated With a High Risk of Pathological Progression of DIC With Suppressed Fibrinolysis

The frequency of severe antithrombin deficiency (SAD) was examined in the hematopoietic disorder-, infectious-, and basic-types of the disseminated intravascular coagulation (DIC). A posthoc analysis of 3008 DIC patients (infectious-type, 1794; hematological disorder-type, 813; and basic-type, 401)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wada, Hideo, Honda, Goichi, Kawano, Noriaki, Uchiyama, Toshimasa, Kawasugi, Kazuo, Madoiwa, Seiji, Takezako, Naoki, Suzuki, Kei, Seki, Yoshinobu, Ikezoe, Takayuki, Iba, Toshiaki, Okamoto, Kohji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448134/ https://www.ncbi.nlm.nih.gov/pubmed/32833540 http://dx.doi.org/10.1177/1076029620941112

Ejemplares similares

Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
por: Wada, Hideo, et al.
Publicado: (2023)

Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure
por: Kawano, Noriaki, et al.
Publicado: (2020)

Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa
por: Kawasugi, Kazuo, et al.
Publicado: (2021)

Clinical Features of Disseminated Intravascular Coagulation According to the French-American-British Classification in Patients With Acute Leukemia and Thrombomodulin Alfa Treatment—A Cohort Study Using a Postmarketing Surveillance Database
por: Yoshinobu, Seki, et al.
Publicado: (2021)

Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis
por: Asakura, Hidesaku, et al.
Publicado: (2016)

The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis
por: Wada, Hideo, et al.
Publicado: (2017)

Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC
por: Madoiwa, Seiji
Publicado: (2015)

Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity
por: Iba, Toshiaki, et al.
Publicado: (2016)

Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin
por: Iba, Toshiaki, et al.
Publicado: (2018)

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey
por: Iba, Toshiaki, et al.
Publicado: (2014)

Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk
por: Suzuki, Kei, et al.
Publicado: (2019)

The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023)

Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation
por: Iba, Toshiaki, et al.
Publicado: (2018)

Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines
por: Wada, Hideo, et al.
Publicado: (2014)

Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on Thrombosis and Haemostasis: a multicenter prospective cohort study
por: Mori, Hirotaka, et al.
Publicado: (2023)

Recent advances in the research and management of sepsis-associated DIC
por: Iba, Toshiaki, et al.
Publicado: (2021)

Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2014)

Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study
por: Mori, Hirotaka, et al.
Publicado: (2022)

Correction: Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study
por: Mori, Hirotaka, et al.
Publicado: (2022)

Marked reductions of protein C and antithrombin in post-trauma DIC have close relations with MODS and poor outcome
por: Gando, S, et al.
Publicado: (2002)

Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study
por: Koyama, Kansuke, et al.
Publicado: (2014)

Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Murao, Atsushi, et al.
Publicado: (2022)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017)

Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model
por: Iba, Toshiaki, et al.
Publicado: (2009)

Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis
por: Iba, Toshiaki, et al.
Publicado: (2020)

The Comparison of the Protective Effects of α- and β-Antithrombin against Vascular Endothelial Cell Damage Induced by Histone in Vitro
por: Iba, Toshiaki, et al.
Publicado: (2017)

A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis
por: Gando, Satoshi, et al.
Publicado: (2013)

Relationship Between Severity of Fibrinolysis Based on Rotational Thromboelastometry and Conventional Fibrinolysis Markers
por: Saito, Tomoyo, et al.
Publicado: (2020)

PAMPs and DAMPs as triggers for DIC
por: Ito, Takashi
Publicado: (2014)

Successful use of an antithrombin for heparin resistance with andexanet alfa
por: Honda, Jun, et al.
Publicado: (2023)

Antithrombin III (AT) and recombinant tissue plasminogen activator (R-TPA) used singly and in combination versus supportive care for treatment of endotoxin-induced disseminated intravascular coagulation (DIC) in the neonatal pig
por: Davis-Jackson, Rachel, et al.
Publicado: (2006)

Supernormal Antithrombin Activity Is an Independent Predictor of In-Hospital Mortality in Patients With Sepsis: A Retrospective Observational Study
por: Azuhata, Takeo, et al.
Publicado: (2020)

DIC/Sun buys Sensient Imaging
Publicado: (2020)

Antithrombin in sepsis revisited
por: Levi, Marcel
Publicado: (2005)

Pharmacological Fibrinolysis
por: Fearnley, G. R.
Publicado: (1969)

Resultados de colecistectomías practicadas en el H.R.S. Papantla entre dic. 1992 - dic 1993
por: Curti González, Niza Yesenia
Publicado: (1999)

Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation
por: Negreva, Mariya, et al.
Publicado: (2016)

Genetic Analysis of a Pedigree With Antithrombin and Prothrombin Compound Mutations and Antithrombin Heterozygotes
por: Zhang, Haiyue, et al.
Publicado: (2022)

Shear rate-dependent thrombosis/fibrinolysis tests using non-anticoagulated blood could be useful in the prevention of thrombotic disorders
por: Yamamoto, Junichiro, et al.
Publicado: (2018)

Quantifying Cyanothece growth under DIC limitation
por: Inomura, Keisuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hnm5493vo0kob2rq8j3p32hr1b